The Future of Psychedelic Medicines

The FDA's recent decision to delay the approval of psychedelic medicines has led the VA and members of Congress to take more direct action. The FDA route may take longer than expected, so discussions in Congress and at the state level are focused on finding another path forward to get these promising treatments in the hands of Veterans in need sooner. The VA is taking a proactive approach by sponsoring research initiatives and establishing specific protocols for psychedelic studies in hopes to gain approval in the near term. Hear from leaders within the VA and Congress on how each is working towards their shared mission to enhance the lives of Veterans.